Alfavision Overs (531156)
Asset PlayScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹15.22 |
| Market Cap | ₹48.64 Cr |
| P/E Ratio | 0 |
| ROCE | 0.07% |
| ROE | -0.16% |
| Dividend Yield | 0% |
| Profit Growth | -500% |
| Debt/Equity | — |
| Sales Growth | -100% |
| 52-Week Range | ₹3.65 — ₹17.18 |
| Sector | Agricultural Food & other Products |
| Book Value | ₹11.79 |
Strengths
- Book value per share of ₹11.79 provides some asset coverage, though price exceeds it.
- P/B at 1.29 is not excessively high, implying market value is not wildly above stated assets.
- ROCE is slightly positive at 0.07%, indicating nominally some capital is at work.
Concerns
- Zero revenue and -100% sales growth show no active business operations.
- Negative ROE and -500% profit growth reflect ongoing losses or collapse.
- Piotroski F-score of 3/9 signals weak financial condition.
- No dividend and negative earnings provide no income or earnings support to valuation.
AI Analysis
Let me apply the same tests I'd use for any business. First, what is the company's earning power? Alfavision Overs has sales of zero in the latest quarter, and sales growth of -100%. A business with no sales is not a business—it's a shell. Profit growth is -500%, ROE is -0.16%. The Piotroski F-score of 3/9 reinforces that this company's financial health is deteriorating. I cannot calculate a meaningful price-to-earnings ratio because there are no earnings. In Graham's world, an investment must provide a margin of safety. Here I'm asked to pay ₹15.22 per share for book value of ₹11.79. That's a P/B of 1.29, meaning a 29% premium to stated net assets. For that premium, I get no sales, no dividend, and no evidence of a moat. The 52-week range of ₹3.65 to ₹17.18 tells me the market is speculating on something—perhaps a turnaround—but I invest in facts, not hopes. Without revenue, I cannot value the enterprise on any earnings basis. The only potential upside lies in hidden asset value, but I'm not given enough to judge the realizable value of those assets. Debt/equity is not available, so I can't even assess leverage. In short, this fails my first rule: never invest in something you can't understand from numbers that prove past performance. Alfavision may eventually find a business, but as a value investor, I will wait for evidence of sales, margins, and competent capital allocation. Until then, this is a pass.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer